NCT06880068Completed
Reliability and Validity of DIDA-Q in Parkinson's Disease
Validity and Reliability of the Dual Task Impact on Daily Living Questionnaire in Patients with Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 17 Mar 2025
Brief summary (registry, in English)
The aim of our study is to investigate the validity and reliability of the Dual Task Impact on Daily-living Activities (DIDA-Q) to assess the degree of difficulty felt when performing dual tasks during activities of daily living in patients with Parkinson's disease. In our study, the validity and reliability of a questionnaire to assess the degree of difficulty felt while performing dual tasks during activities of daily living in Parkinson's Disease will be examined for the first time. The study will include 95 participants with Hoehn-Yahr Stage 1-3, diagnosed with Idiopathic Parkinson's Disease and able to walk 10 metres without an assistive device.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 95 (actual)
- First submitted
- 13 Jan 2025
- Start date
- 13 Jan 2024
- Primary completion date
- 1 Jan 2025
- Lead sponsor
- Marmara University
- Diseases
- Parkinson disease
- NCT number
- NCT06880068
What you commit to
- Study type: Observational
- Participants enrolled: 95
- From 13 Jan 2024 to the primary completion date, 1 Jan 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Having any neurological disease other than idiopathic Parkinson's Disease
- The person has an orthopaedic or cardiopulmonary disease that affects walking
- Severe hearing-visual impairment
Who the study is looking for
- Diagnosed with Idiopathic Parkinson's Disease according to UK Brain Bank criteria
- Walking at least 10 metres without an assistive device
- To have the cognitive capability to understand and answer the questions asked in the scale
Age in the registry: 39 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Istanbul University, Faculty of Medicine Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.